Promising hit compounds against resistant trichomoniasis: Synthesis and antiparasitic activity of 3-(ω-aminoalkoxy)-1-benzyl-5-nitroindazoles

Impacto

Downloads

Downloads per month over past year

Ibáñez Escribano, Alexandra and Reviriego, Felipe and Vela, Nerea and Fonseca Berzal, Cristina Rosa and Nogal Ruiz, Juan José and Arán, Vicente J. and Escario Garcia-Trevijano, José Antonio and Gómez Barrio, Alicia (2021) Promising hit compounds against resistant trichomoniasis: Synthesis and antiparasitic activity of 3-(ω-aminoalkoxy)-1-benzyl-5-nitroindazoles. Bioorganic & Medicinal Chemistry Letters, 37 . p. 127843. ISSN 0960894X

[thumbnail of 1-s2.0-S0960894X2100069X-main.pdf]
Preview
PDF
Creative Commons Attribution Non-commercial No Derivatives.

671kB

Official URL: https://doi.org/10.1016/j.bmcl.2021.127843




Abstract

A series of 11 3-(ω-aminoalkoxy)-1-benzyl-5-nitroindazoles (2–12) has been prepared starting from 1-benzyl-5-nitroindazol-3-ol 13, and evaluated against sensitive and resistant isolates of the sexually transmitted protozoan Trichomonas vaginalis. Compounds 2, 3, 6, 9, 10 and 11 showed trichomonacidal profiles with IC50 < 20 µM against the metronidazole-sensitive isolate. Moreover, all these compounds submitted to cytotoxicity assays against mammalian cells exhibited low non-specific cytotoxic effects, except compounds 3 and 9 which displayed moderate cytotoxicity (CC50 = 74.7 and 59.1 µM, respectively). Those compounds with trichomonacidal effect were also evaluated against a metronidazole-resistant culture. Special mention deserve compounds 6 and 10, which displayed better IC50 values (1.3 and 0.5 µM respectively) than that of the reference drug (IC50 MTZ = 3.0 µM). The high activity of these compounds against the resistant isolate reinforces the absence of cross-resistance with the reference drug. The remarkable trichomonacidal results against resistant T. vaginalis isolates suggest the interest of 3-(ω-aminoalkoxy)-1-benzyl-5-nitroindazoles to be considered as good prototypes to continue in the development of new drugs with enhanced trichomonacidal activity, aiming to increase the non-existent drugs to face clinical resistance efficiently for those patients in whom therapy with 5-nitroimidazoles is contraindicated.


Item Type:Article
Additional Information:

CRUE-CSIC (Acuerdos Transformativos 2021)

Uncontrolled Keywords:Antiprotozoal agents; IndazoleNitrogen heterocycles; Trichomonas vaginalisResistance
Subjects:Medical sciences > Pharmacy > Parasitology
ID Code:70434
Deposited On:14 Feb 2022 13:39
Last Modified:21 Feb 2022 15:08

Origin of downloads

Repository Staff Only: item control page